Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03308617
Other study ID # JenaUC
Secondary ID
Status Recruiting
Phase N/A
First received October 9, 2017
Last updated October 11, 2017
Start date April 1, 2017
Est. completion date June 1, 2020

Study information

Verified date October 2017
Source Jena University Hospital
Contact Monique Kribus, Dr. med.
Phone 0049-3641-9322801
Email monique.kribus@med.uni-jena.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Peri-implant infections are severe complications after internal fracture fixation surgery. Detection of causative agents of orthopedic implant-associated infections (OIAI) is demanding. Several authors reported increased identification rates of bacterial prevalence using different sonication procedures compared to standard tissue cultures samples, especially for low grade infections.

On the author hand, contamination of implants without clinical signs of infection is reported in up to 30% during implant removals after uneventful fracture healing. The raised general questions are: 1.) Is a positive microbiological finding the result of contamination during the index surgery or during implant removal? 2.) Does contaminated implants without clinical or serological signs of infection have a pathological value?


Description:

In this prospective case study, the detection rates of different diagnostic tools for peri-implant contaminations during removal of syndesmotic screws should be compared and the clinical consequence of positive findings evaluated in follow up investigations up to 6 months.

Patients with ankle fractures (Weber B and C) treated operatively in our department by open reduction and internal fixation with plates and additional syndesmotic screw should be included. After patients´ informed consent, several microbiological samples should be taken for further microbiological analysis during the standard syndesmotic screw removal 6-8 weeks after the index surgery. At follow up of two weeks after screw removal a clinical examination and serological analysis for infection will be performed. The endpoint of study is fracture healing at six months.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date June 1, 2020
Est. primary completion date December 1, 2019
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with syndesmotic screw removal after open reduction and internal fixation with plates and additional syndesmotic screw of ankle fractures (Weber B or C) in our department.

Exclusion Criteria:

- Patients with immunosuppressive diseases or therapies,

- Pregnant women

- Patients with pre-operations on the same ankle-joint

- Patients with initial surgery for fracture fixation in other hospitals.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Department of Trauma-, Hand- and Reconstructive Surgery Jena Thüringen

Sponsors (1)

Lead Sponsor Collaborator
Jena University Hospital

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Detection rate of syndesmotic screw contamination using a sonication procedure compared to standard wound swabs six weeks
Secondary Clinical manifestation of infections by contaminated fracture fixation implants six months